Insider Trading History of Landis John B.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Landis John B. since 2012. This trader's CIK number is 1477283. At the time of last reporting, Landis John B. was the Officer of Eyepoint Pharmaceuticals, Inc.. (stock ticker symbol EYPT). Also see all insider trading activities at Eyepoint Pharmaceuticals, Inc..

Note that in the past Landis John B. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Inotiv, Inc. (BASI) by Landis John B.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 BASI 30,000 $37,800 0 $0 0 $0

Yearly summary of insider trading at Eyepoint Pharmaceuticals, Inc. (EYPT) by Landis John B.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 EYPT 0 $0 0 $0 10,000 $0
2023 EYPT 0 $0 0 $0 3,000 $0
2022 EYPT 0 $0 0 $0 2,500 $0
2021 EYPT 0 $0 0 $0 1,900 $0
2019 EYPT 40,000 $69,600 0 $0 0 $0


Insider trading activities at 2 companies by Landis John B.:

1. Inotiv, Inc. (BASI)

2. Eyepoint Pharmaceuticals, Inc. (EYPT)

Table 1. Insider trading of Inotiv, Inc. (BASI) by Landis John B.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-08-17 BASI Buy 30,000 1.26 37,800

Table 2. Insider trading of Eyepoint Pharmaceuticals, Inc. (EYPT) by Landis John B.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-01-05 EYPT Option Ex 10,000 .00 0
2023-02-09 EYPT Option Ex 3,000 .00 0
2022-02-09 EYPT Option Ex 2,500 .00 0
2021-02-28 EYPT Option Ex 1,900 .00 0
2019-05-13 EYPT Buy 40,000 1.74 69,600

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Landis John B. (Officer of Eyepoint Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.